SynAct Pharma AB SYNACT.ST
SYNACT.ST
SynAct Pharma AB ONCO.ST
Oncopeptides AB (publ) XSPRAY.ST
Xspray Pharma AB (publ) ITECH.ST
I-Tech AB IBT-B.ST
Infant Bacterial Therapeutics AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) GENO.ST
Genovis AB (publ.) ORX.ST
Orexo AB (publ) SEDANA.ST
Sedana Medical AB (publ) CANTA.ST
Cantargia AB (publ)
SynAct Pharma AB ONCO.ST
Oncopeptides AB (publ) XSPRAY.ST
Xspray Pharma AB (publ) ITECH.ST
I-Tech AB IBT-B.ST
Infant Bacterial Therapeutics AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) GENO.ST
Genovis AB (publ.) ORX.ST
Orexo AB (publ) SEDANA.ST
Sedana Medical AB (publ) CANTA.ST
Cantargia AB (publ)
Performance
| Periode | SYNACT.ST | ONCO.ST | XSPRAY.ST | ITECH.ST | IBT-B.ST | DMYD-B.ST | GENO.ST | ORX.ST | SEDANA.ST | CANTA.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 20.43 % | 167.54 % | -27.94 % | -4.83 % | 12.15 % | 38.42 % | -3.17 % | 119.10 % | 12.87 % | 50.96 % |
| YTD | 132.62 % | 223.42 % | -39.32 % | 24.67 % | 4.53 % | -37.28 % | -6.15 % | 71.05 % | -37.50 % | 38.53 % |
| 1Y | 144.38 % | 144.50 % | -54.81 % | 53.28 % | 63.49 % | -17.69 % | 3.15 % | 187.29 % | -25.29 % | -20.17 % |
| 3Y | -55.70 % | -42.13 % | -53.97 % | 51.42 % | 6.95 % | -18.51 % | -38.11 % | 61.66 % | -55.50 % | -35.90 % |
| 5Y | -51.67 % | -95.68 % | -81.13 % | 13.33 % | -56.90 % | -65.92 % | -20.35 % | -35.87 % | -81.98 % | -95.79 % |
| 10Y | 335.78 % | -83.32 % | -14.97 % | 203.20 % | 2.63 % | 78.35 % | 1 002.14 % | -44.53 % | 91.60 % | -70.98 % |
| From the beginning | 335.78 % | -83.32 % | -14.97 % | 203.20 % | 2.63 % | 225.83 % | -53.21 % | -65.31 % | 91.60 % | -72.27 % |